Revolution Medicines, a clinical-stage precision oncology firm based in Redwood City, California, focuses on developing targeted therapies, including RAS(ON) inhibitors and companion inhibitors, currently in clinical development. The company went public on February 13, 2020, and employs 411 staff.
RVMD has been in the news recently: Revolution Medicines Inc. (NASDAQ:RVMD) experienced a decline in its stock price after AbbVie Inc. (NYSE:ABBV) denied ongoing acquisition discussions, ending a 28% rally. This dip occurred despite gains reported by other companies in the market, which highlighted increased revenue and profits in their sectors.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.